Summary of Product Development and Product Launch Activities

➢ April 1 2011. Sign Licensing agreement for platform technology with NUS

➢ March 2012 Obtain Health Canada Approval for NutraPause

➢ July 2012 Obtained Health Canada Approval for Amended claims for NutraPause

➢ August 2012 Obtain Health Canada Review of Submission for Cardio Health Product

➢ January 2012- June 2013 Entered agreement with Johnson and Johnson (J&J) who performed all of the Quality Controls

   on the product and our selected packaging company in Singapore and manufacturer

➢ March 2013 Incorporated USA Affiliate

➢ January to March 2013 Signed a Shareholders Agreement with Keith Larson appointed as Director and President of

   USA affiliate

➢ June 2013 Obtained Health Canada approval for OsteoProtect

➢ July 2013 Entered into an Exclusive Distribution Agreement with TFB and Associated for Canada alone.

➢ December 2013 Signed contract manufacturing agreements

➢ January 2014 TFB and Associates completes agreements with Safeway Canada and tentative agreements with Rexall

   and IDA/Guardian

➢ February/March 2016 Planned Launch for Nutrapause in Canada

➢ July 2016 Planned online Launch for Nutrapause in the USA

➢ September 2016 Health Canada submission for Cardio-Plus

➢ January 2017 Planned launch for OsteoProtect in Canada and USA 

➢ April 2017 Planned Launch for CardioPlus Product in Canada and USA 

➢ September 2017 Planned Launch for Nutrapause in Europe